Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shigeaki Hayashida is active.

Publication


Featured researches published by Shigeaki Hayashida.


BJUI | 2011

Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines

Shigeru Sakano; Hideyasu Matsuyama; Kimio Takai; Satoru Yoshihiro; Yoriaki Kamiryo; Satoshi Shirataki; Yoshitaka Kaneda; Osamu Hashimoto; Keiji Joko; Akinobu Suga; Mitsutaka Yamamoto; Shigeaki Hayashida; Yoshikazu Baba; Akihiko Aoki

Study Type – Therapy (case series) 
Level of Evidence 4


Mutation Research\/genetic Toxicology | 1984

Mutagenicity of urine of various species fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or 2-amino-4-(5-nitro-2-furyl)thiazole☆

Shigeaki Hayashida; Ching Yung Wang

Rats, mice and hamsters, which are susceptible to the bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT), and guinea pigs, which are not, were fed a diet containing 0.188% FANFT or 0.188% 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) for 1 week and their urine was then examined for mutagenicity for S. typhimurium TA100. The mutagenicities of the urine of these species fed FANFT were approximately equal. Similarly, that of the urine of these species fed ANFT were also approximately equal. However, the urine from FANFT-fed animals was approximately 10 times as mutagenic as that from ANFT-fed animals. ANFT was detected only in the urine of rats, mice or hamsters fed FANFT. A positive correlation between the susceptibility toward bladder carcinogenesis by FANFT and urinary ANFT excretion was demonstrated, although the correlation between this susceptibility and urine mutagenicity was lacking.


Cancer Letters | 1987

Production of urinary tract tumors by co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in F344 rats

Ching Yung Wang; Yoriaki Kamiryo; Shigeaki Hayashida; William A. Croft

Co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) to weanling female Fischer rats produced uracil stones in the bladder and significantly reduced the incidence of bladder tumors. Contrary to bladder tumors, the incidence of renal pelvic and ureteric tumors was increased by this regimen. Feeding of uracil alone produced bladder tumors, in addition to the hyperplasia of renal pelvis, ureter and bladder. The mechanism of uracils effect on FANFT carcinogenesis is not known.


Cancer Letters | 1984

Enhancement by phenothiazine and 2,5-di-O-acetyl-d-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats

Ching Yung Wang; Shigeaki Hayashida

Rats concomitantly fed N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) and phenothiazine, or concomitantly fed FANFT and Glucaron then fed Glucaron alone had significantly greater incidences of transitional cell carcinomas of the bladder than rats fed FANFT alone. Caffeine and cysteamine did not affect FANFT bladder carcinogenesis. Phenothiazine induced nitroreductase activity of hepatic microsomes.


Cancer Research | 1976

Enhancing Effect of Allopurinol on the Induction of Bladder Cancer in Rats by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide

Ching Yung Wang; Shigeaki Hayashida; A. Mahir Pamukcu; George T. Bryan


Annals of Surgical Oncology | 2013

Risk Group Stratification Based on Preoperative Factors to Predict Survival after Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma

Shigeru Sakano; Hideyasu Matsuyama; Yoriaki Kamiryo; Shigeaki Hayashida; Norio Yamamoto; Yoshitaka Kaneda; Takahito Nasu; Osamu Hashimoto; Keiji Joko; Yoshikazu Baba; Tomoyuki Shimabukuro; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; Masafumi Matsumura


International Journal of Clinical Oncology | 2015

Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma

Shigeru Sakano; Hideyasu Matsuyama; Yoriaki Kamiryo; Shigeaki Hayashida; Norio Yamamoto; Yoshitaka Kaneda; Takahito Nasu; Yoshikazu Baba; Tomoyuki Shimabukuro; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; Kazuo Oba


International Journal of Clinical Oncology | 2016

Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer

Takahiko Hara; Hideyasu Matsuyama; Yoriaki Kamiryo; Shigeaki Hayashida; Norio Yamamoto; Takahito Nasu; Keiji Joko; Yoshikazu Baba; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; M Konishi; Sigeru Sakano; Katsuhiko Imoto; Yasuhide Tei; Shiro Yamaguchi; Seiji Yano


Jpn J Nephrol | 1997

Study on coagulation and fibrinolytic systems in predialysis patients with chronic renal failure. Comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy.:—Comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy—

Yoshio Nagake; Hirofumi Makino; Noriaki Yorioka; Shinsuke Nomura; Gengo Osawa; Michio Yamakido; Hironaka Kawasaki; Yuzuru Kato; Masunori Matsuzaki; Kenichi Shikata; Jiro Uemasu; Hajime Somiya; Zenzo Fujii; Shigeaki Hayashida; Takahito Nasu; Yasuhiko Oyabub; Yutaka Nitta; Hideki Kawanishi; Koji Usui; Kenta Fujiwara; Norihisa Takasugi; Koji Kanehara; Naoki Hamaguchi; Isao Kumagai; Haruo Ichikawa; Maki Takahashi; Hiroyuki Omori; Katsuhiko Arimoto; Yasuaki Mino; Kenji Kawabata


Journal of Japanese Society for Dialysis Therapy | 1992

Efficacy of erythropoietin in CAPD patients; comparison between intravenous and intraperitoneal administration.

Takahito Nasu; Hiroshi Mitsui; Yoichi Shinohara; Shigeaki Hayashida; Hiroyuki Otsuka

Collaboration


Dive into the Shigeaki Hayashida's collaboration.

Top Co-Authors

Avatar

Ching Yung Wang

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge